Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose oral minoxidil combined with topical minoxidil improves hair growth in breast cancer patients with therapy-induced hair loss.

Tofacitinib helped regrow hair in a teen with a unique pattern of alopecia areata.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Certain cancer drugs can cause skin issues like rashes and itching.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

K10 may not prevent tumors as previously thought and might increase benign tumor risk.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.